Rafael Tomoya Michita

Concepts (106)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HLA-G Antigens
6
2022
13
1.410
Why?
Histocompatibility Antigens Class I
5
2019
105
1.000
Why?
3' Untranslated Regions
6
2022
166
1.000
Why?
Genotype
12
2022
2703
0.710
Why?
Genetic Predisposition to Disease
9
2022
3358
0.660
Why?
Cytomegalovirus Infections
4
2018
224
0.610
Why?
Polymorphism, Single Nucleotide
9
2022
2851
0.600
Why?
Abortion, Habitual
2
2019
17
0.550
Why?
Graft Rejection
3
2019
559
0.530
Why?
Interleukin-1beta
2
2020
163
0.440
Why?
NK Cell Lectin-Like Receptor Subfamily K
2
2018
16
0.440
Why?
Dyspepsia
2
2020
108
0.430
Why?
Genetic Variation
2
2022
1580
0.420
Why?
Kidney Transplantation
6
2019
571
0.400
Why?
Mesocricetus
1
2021
74
0.360
Why?
Polymorphism, Genetic
3
2018
803
0.350
Why?
Receptors, CCR5
1
2019
31
0.320
Why?
Fas Ligand Protein
1
2019
37
0.310
Why?
fas Receptor
1
2019
47
0.300
Why?
bcl-2-Associated X Protein
1
2019
71
0.300
Why?
Gene Frequency
5
2021
750
0.300
Why?
HIV Infections
3
2019
2049
0.290
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
180
0.290
Why?
Brazil
5
2021
140
0.290
Why?
Hepatitis B
1
2019
172
0.280
Why?
Cytochrome P-450 CYP2B6
1
2017
15
0.270
Why?
Benzoxazines
1
2017
24
0.270
Why?
Amino Acid Substitution
1
2018
409
0.260
Why?
Reverse Transcriptase Inhibitors
1
2017
38
0.260
Why?
Living Donors
4
2019
116
0.250
Why?
Gastritis
1
2020
372
0.250
Why?
Transplantation Tolerance
1
2016
15
0.250
Why?
Haplotypes
4
2022
545
0.240
Why?
Helicobacter pylori
2
2020
1336
0.240
Why?
Helicobacter Infections
2
2020
1278
0.240
Why?
Antibodies, Viral
1
2021
1204
0.230
Why?
Central Nervous System
1
2017
283
0.230
Why?
Hepatitis C, Chronic
1
2019
370
0.230
Why?
Ovarian Neoplasms
1
2019
462
0.220
Why?
Genetic Association Studies
4
2022
857
0.210
Why?
Alleles
5
2022
1685
0.200
Why?
Adult
15
2022
31614
0.200
Why?
Middle Aged
14
2022
29021
0.190
Why?
Inflammation
1
2020
1522
0.190
Why?
Disease Models, Animal
1
2021
4690
0.170
Why?
Carcinoma, Hepatocellular
1
2019
984
0.170
Why?
Prognosis
5
2022
5016
0.160
Why?
Female
17
2022
70787
0.160
Why?
BK Virus
1
2019
60
0.150
Why?
Breast Neoplasms
1
2022
2681
0.150
Why?
Liver Neoplasms
1
2019
1381
0.150
Why?
Polyomavirus Infections
1
2019
91
0.150
Why?
Virus Replication
2
2019
636
0.140
Why?
Kidney Diseases
2
2019
490
0.140
Why?
Viral Load
2
2021
408
0.140
Why?
Viremia
1
2018
133
0.140
Why?
Cytomegalovirus
1
2018
262
0.130
Why?
Male
13
2021
65014
0.120
Why?
Humans
17
2022
132247
0.100
Why?
Transplant Recipients
3
2018
225
0.090
Why?
Coinfection
2
2019
188
0.090
Why?
Alcoholism
1
2014
250
0.090
Why?
Cricetinae
1
2021
381
0.090
Why?
Tumor Burden
1
2022
248
0.090
Why?
Tissue Donors
2
2018
503
0.080
Why?
Young Adult
3
2022
9966
0.080
Why?
Hepatitis C
1
2014
387
0.080
Why?
Aged
4
2022
21482
0.080
Why?
Substance-Related Disorders
1
2014
491
0.080
Why?
Aged, 80 and over
2
2022
7138
0.070
Why?
Hepatitis B virus
1
2019
141
0.070
Why?
Pancreas Transplantation
1
2018
31
0.070
Why?
Valine
1
2018
111
0.070
Why?
Sex Factors
1
2021
1354
0.070
Why?
CD4-CD8 Ratio
1
2017
13
0.070
Why?
Alkynes
1
2017
29
0.070
Why?
Cyclopropanes
1
2017
71
0.060
Why?
Precancerous Conditions
1
2020
280
0.060
Why?
Adolescent
3
2022
20557
0.060
Why?
Anti-Bacterial Agents
1
2018
2552
0.060
Why?
Kaplan-Meier Estimate
1
2019
1128
0.060
Why?
HIV-1
1
2019
484
0.060
Why?
Postoperative Complications
1
2017
3139
0.060
Why?
Neoplasm Staging
1
2019
1365
0.060
Why?
Pregnancy
2
2019
7557
0.060
Why?
Lung
1
2021
1556
0.050
Why?
Biomarkers, Tumor
1
2022
1683
0.050
Why?
Case-Control Studies
1
2019
3414
0.050
Why?
Omeprazole
1
2018
101
0.030
Why?
Anti-Ulcer Agents
1
2018
115
0.030
Why?
Clarithromycin
1
2018
127
0.030
Why?
Amoxicillin
1
2018
120
0.030
Why?
Prospective Studies
1
2017
6568
0.030
Why?
Mutation
1
2019
6250
0.030
Why?
Double-Blind Method
1
2018
1653
0.030
Why?
Protein Binding
1
2018
1734
0.030
Why?
Transcription, Genetic
1
2018
1423
0.030
Why?
Educational Status
1
2014
294
0.020
Why?
Kidney
1
2018
1338
0.020
Why?
Animals
1
2021
34854
0.020
Why?
Follow-Up Studies
1
2018
5410
0.020
Why?
Cohort Studies
1
2018
5176
0.020
Why?
Prevalence
1
2014
2664
0.020
Why?
Cross-Sectional Studies
1
2014
3761
0.010
Why?
Treatment Outcome
1
2018
13027
0.010
Why?
Risk Factors
1
2014
10945
0.010
Why?
Tomoya Michita's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (106)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_